Rigel Pharmaceuticals Inc (RIGL)
R&D Expense Growth
19.57%
Quarterly · Period ending:
RIGL R&D Expense Growth
Latest reported19.57%period ending
Latest reported19.57%period ending
RIGL Quarterly R&D Growth (QoQ) (0.00% → 19.57%)
Latest values, visible window
High-resolution chart · PNG
RIGL r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 47.0136% | |
| -81.3417% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |